Skip to content

Anna Katja Maria Chesterman, MD

NPI 1992407100ActiveIndividual· Internal Medicine, Pulmonary Disease· Roseville, CA

Internal Medicine, Pulmonary Disease (MD) in Roseville, California, licensed in CA, with an NPI issued in March 2023. Part D covered 354 prescriptions written in 2024, 81% of them generic. Jazz Pharmaceuticals Inc. reported $26.68 in payments in 2025, mostly food and beverage.

Overview

NPI1992407100
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 21, 2023
Last updated in NPPESAug 21, 2026
Certified by providerAug 21, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001XA210083CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (FL)

Part D prescriptions in 2024

Prescriptions (claims)354 · 652 30-day fills
Patients65
Total drug cost$58,831
Generic share81% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$26.68 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Jazz Pharmaceuticals Inc.$26.681

What the 2025 payments were for

  • Food and Beverage$26.68 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Roseville

All Internal Medicine, Pulmonary Disease providers in California →